March 2026 – Perseus SENOLYTIX

March 2026

Pulmatrix picked for reverse merger with anti-aging biotech weeks after Cullgen deal collapses

March 27, 2026

Pulmatrix and Eos merge to advance gerotherapeutics

March 26, 2026

Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan

March 26, 2026

Sustained visceral fat loss is associated with attenuated brain atrophy and improved cognitive function in late midlife

March 4, 2026

Categories

Archives

© 2026 Perseus SENOLYTIX.